Hopp til innhold
NHI.no
Annonse

Katekolaminer eller VMA, urinprøve: Feilkilder

Stress og fysiske anstrengelser kan medføre at katekolaminverdier i urinen overstiger øvre referansegrense. Korrekte prøvesvar avhenger av at døgnurin er samlet på riktig måte Prøvetaking bør skje under eller like etter perioder med symptomer på økt katekolaminproduksjon. Utskillelse av hormoner fra en eventuell hormonproduserende svulst kan være støtvis.

Annonse

Dette dokumentet er basert på det profesjonelle dokumentet Feokromocytom . Referanselisten for dette dokumentet vises nedenfor

  1. Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2014; 99: 1915-42. pmid:24893135 PubMed
  2. Medical Masterclass contributors, Firth J. Endocrinology: phaeochromocytoma. Clin Med (Lond). 2019;19(1):68-71. PubMed
  3. Carlsen S, Methlie P. Feokromocytom og paragangliom. Nasjonal veileder i endokrinologi. Sist oppdatert 28.09.2021. www.endokrinologi.no
  4. Elhassan YS, Alahdab F, Prete A, et al. Natural History of Adrenal Incidentalomas With and Without Mild Autonomous Cortisol Excess: A Systematic Review and Meta-analysis. Ann Intern Med 2019. pmid:31234202 PubMed
  5. Jing Y, Hu J, Luo R, et al. Prevalence and Characteristics of Adrenal Tumors in an Unselected Screening Population A Cross-Sectional Study. Ann Intern Med 2022. pmid:36095315 PubMed
  6. Eisenhofer G, Bornstein SR, Brouwers FM et al. Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer 2004; 11: 423-36. PubMed
  7. Husebye ES, Varhaug JE, Heimdal K. Arvelige endokrine tumorsykdommer. Tidsskr Nor Lægeforen 2005; 125: 2964-7. PubMed
  8. Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G and Plouin PF. Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab 2005; 90: 2110-6. PubMed
  9. Nazari MA, Hasan R, Haigney M, et al. Catecholamine-induced hypertensive crises: current insights and management. Lancet Diabetes Endocrinol 2023. pmid:37944546 PubMed
  10. Pamporaki C, Berends AMA, Filippatos A, et al. Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohort. Lancet 2023. pmid:37474439 PubMed
  11. Young WF. Clinical presentation and diagnosis of pheochromocytoma. UpToDate, last updated Apr 13, 2021. UpToDate
  12. Jones AG, Evans PH, Vaidya B. Phaeochromocytoma. BMJ 2012; 344: e1042. PMID: 22349579 PubMed
  13. Young WF, Kebebew E. Treatment of pheochromocytoma in adults. UpToDate, last updated Feb 12, 2021. UpToDate
  14. Plouin PF, Amar L, Dekkers OM, el al. European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol 2016; 174: G1-G10. PMID: 27048283 PubMed
Annonse
Annonse